SAFETY AND IMMUNOGENICITY OF BNT162B2 MRNA COVID-19 VACCINE AMONG ADOLESCENTS WITH RHEUMATIC DISEASES TREATED WITH IMMUNOMODULATORY MEDICATIONS

被引：0

作者：

Heshin-Bekenstein, M. ^{[1
,2
]}

Ziv, A. ^{[2
,3
]}

Toplak, N. ^{[4
]}

Hagin, D. ^{[2
,5
]}

Kadishevich, D. ^{[6
]}

Butbul, Y. ^{[7
]}

Saiag, E. ^{[8
]}

Shefer, G. ^{[9
]}

Sharon, O. ^{[9
]}

Pel, S. ^{[10
]}

Elkayam, O. ^{[2
,10
]}

Uziel, Y. ^{[2
,3
]}

机构：

[1] Dana Dwek Childrens Hosp, Pediat Rheumatol Serv, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel

[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel

[3] Meir Med Ctr, Pediat Rheumatol Unit, Kefar Sava, Israel

[4] Univ Childrens Hosp, Univ Med Ctr Ljubljana, Dept Allergol Rheumatol & Clin Immunol, Ljubljana, Slovenia

[5] Tel Aviv Med Ctr & Sch Med, Allergy & Clin Immunol Unit, Tel Aviv, Israel

[6] Meir Med Ctr, Pediat, Kefar Sava, Israel

[7] Ruth Rappaport Childrens Hosp, Pediat Rheumatol Serv, Rambam Med Ctr, Haifa, Israel

[8] Tel Aviv Sourasky Med Ctr, Hosp Management, Informat & Operat Branch, Tel Aviv, Israel

[9] Tel Aviv Sourasky Med Ctr, Dept Endocrinol Metab & Hypertens, Tel Aviv, Israel

[10] Tel Aviv Sourasky Med Ctr, Dept Rheumatol, Tel Aviv, Israel

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷

关键词：

D O I：

10.1136/annrheumdis-2022-eular.4691

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0258

引用

页码：370 / 371

页数：2

共 50 条

[31] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy
Dagan, Noa
Barda, Noam
Biron-Shental, Tal
Makov-Assif, Maya
Key, Calanit
Kohane, Isaac S.
Hernan, Miguel A.
Lipsitch, Marc
Hernandez-Diaz, Sonia
Reis, Ben Y.
Balicer, Ran D.
NATURE MEDICINE, 2021, 27 (10) : 1693 - +
[32] Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis
Michos, Athanasios
Filippatos, Filippos
Tatsi, Elizabeth-Barbara
Dellis, Charilaos
Efthymiou, Vasiliki
Zarkada, Ioanna
Troupi, Evgenia
Syriopoulou, Vasiliki
Loukou, Ioanna
JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (03) : E184 - E187
[33] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy
Noa Dagan
Noam Barda
Tal Biron-Shental
Maya Makov-Assif
Calanit Key
Isaac S. Kohane
Miguel A. Hernán
Marc Lipsitch
Sonia Hernandez-Diaz
Ben Y. Reis
Ran D. Balicer
Nature Medicine, 2021, 27 : 1693 - 1695
[34] Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines Against COVID-19 Infection Among Patients With Systemic Autoimmune Rheumatic Diseases on Immunomodulatory Medications
Cook, Claire E.
Patel, Naomi J.
Fu, Xiaoqing
Wang, Xiaosong
Kawano, Yumeko
Vanni, Kathleen M. M.
Qian, Grace
Banasiak, Emily
Kowalski, Emily
Choi, Hyon K.
Zhang, Yuqing
Sparks, Jeffrey A.
Wallace, Zachary S.
JOURNAL OF RHEUMATOLOGY, 2023, 50 (05) : 697 - 703
[35] Immunogenicity of a Fractional Dose of mRNA BNT162b2 COVID-19 Vaccine for Primary Series and Booster Vaccination among Healthy Adolescents
Puthanakit, Thanyawee
Chantasrisawad, Napaporn
Yoohat, Kirana
Nantanee, Rapisa
Sophonphan, Jiratchaya
Meepuksom, Thutsanun
Sodsai, Pimpayao
Phanthanawiboon, Supranee
Jantarabenjakul, Watsamon
Hirankarn, Nattiya
Kosalaraksa, Pope
VACCINES, 2022, 10 (10)
[36] BNT162b2 mRNA COVID-19 Vaccine: First Approval
Lamb, Yvette N.
DRUGS, 2021, 81 (04) : 495 - 501
[37] Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine
Lopez-Valle, Alba
Falkenhain-Lopez, Daniel
Arranz, Celia R.
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (07) : 891 - 892
[38] Immunogenicity and safety of BNT162b2 COVID-19 vaccine in a chronic lymphocytic leukaemia patient
Agrati, Chiara
Castilletti, Concetta
Sacchi, Alessandra
Colavita, Francesca
Capobianchi, Maria Rosaria
Puro, Vincenzo
Nicastri, Emanuele
Ippolito, Giuseppe
Bibas, Michele
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (13) : 6460 - 6462
[39] Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine
Tumminia, Andrea
Romano, Marcello
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (02): : 191 - 191
[40] BNT162b2 mRNA COVID-19 Vaccine: First Approval
Yvette N. Lamb
Drugs, 2021, 81 : 495 - 501

← 1 2 3 4 5 →